Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
β1-adrenergic agonist, β2- and α1-adrenergic...
Macrolide lactone antibiotic.
Sphingosine 1-phosphate antagonist.
Polyether Ca2+ ionophore.
ROCK inhibitor.
Protease substrate.
Nitrogen mustard, DNA alkylator.
Modifies microvascular function
NSAID; COX inhibitor and HS-releasing agent.
EGFR (WT, T790M) inhibitor.
ITC, used as chiral agent.
H+/K+ ATPase and ROCK-2 inhibitor.
Voltage-gated K+ channel blocker.
CDK4/6 inhibitor.
Fermentation impurity
Endogenous peptide hormone, GLP-1 fragment, inv...
Aminoquinoline, binds heme, causes cell lysis.<...
H1 histamine and LT antagonist, PDE inhibitor.<...
FIASMA, 5-HT1/2, M1-5 mAChR, α1-adrenergic, hi...
PDEδ inhibitor.